Semaglutide is a medication that has been approved by the U.S. Food and Drug Administration (FDA) for weight management in adults with obesity or overweight and at least one weight-related condition. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means that it mimics the action of a natural hormone in the body called GLP-1. GLP-1 is released by the intestines in response to food intake and helps regulate blood sugar levels by stimulating insulin release and reducing glucagon secretion. GLP-1 also promotes feelings of fullness and reduces food intake by slowing down the emptying of the stomach and increasing satiety signals to the brain.
1 in stockBook